US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Atorvastatin Calcium Tablets

Reason Presence of foreign substance: Foreign matter has been identified as latex glove in one lot of Atorvastatin Calcium Tablets USP 40 mg.

Sun Pharmaceutical Industries, Inc. NDC 63304-829-05 D-1047-2020
Class II · Moderate risk Terminated

Sotalol HCL Tablets

Reason Presence of particulate matter. presence of metal particles.

Mylan Pharmaceuticals Inc. NDC 00378-5123-01 D-1031-2020
Class II · Moderate risk Terminated

Theophylline

Reason CGMP Deviations: poor manufacturing practices resulted in Labeling: Incorrect or Missing Lot and/or Exp Date, product incorrectly labeled with incorrect lot and expiration date.

Nostrum Laboratories Inc NDC 29033-001-01 D-1059-2020
Class II · Moderate risk Terminated

Acetaminophen 500 mg tablet packaged in a) 30-count bottles

Reason Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle

H J Harkins Company Inc dba Pharma Pac NDC 52959-0002-30 D-1005-2020
Class II · Moderate risk Terminated

Epinephrine Injection USP

Reason CGMP Deviations: Precautions taken due to Out-of-specification for trigger force for a non-marketed lot number that shares the same component.

Teva Pharmaceuticals USA NDC 0093-5986-27 D-1260-2020
Class II · Moderate risk Terminated

Sodium Chloride 0.9% Injection

Reason CGMP Deviation: Chemical indicators were not positioned properly during sterilization process.

Fresenius Medical Care Holdings, Inc. D-1064-2020
Class II · Moderate risk Terminated

Peppermint Lip Moisturizer

Reason Superpotent drug: This lot of SPF containing lip balm contains up to 150% of the label claim for active ingredient Oxybenzone.

Yusef Manufacturing Laboratories, LLC D-1251-2020
Class II · Moderate risk Terminated

Daytrana

Reason Defective Delivery System: Out of specification for mechanical peel and shear.

Noven Therapeutics, LLC NDC 68968-5555-3 D-1045-2020
Class II · Moderate risk Terminated

Daytrana

Reason Defective Delivery System: Out of specification for mechanical peel and shear.

Noven Therapeutics, LLC NDC 68968-5554-3 D-1044-2020
Class II · Moderate risk Terminated

Daytrana

Reason Defective Delivery System: Out of specification for mechanical peel and shear.

Noven Therapeutics, LLC NDC 68968-5553-3 D-1043-2020
Class II · Moderate risk Terminated

Daytrana

Reason Defective Delivery System: Out of specification for mechanical peel and shear.

Noven Therapeutics, LLC NDC 68968-5552-3 D-1042-2020
Class II · Moderate risk Terminated

Carbidopa and Levodopa Tablets

Reason Product Mix-Up: A foreign tablet was found in bottle.

Mayne Pharma Inc NDC 51862-858-01 D-0998-2020
Class II · Moderate risk Terminated

Elelyso

Reason Lack of Assurance of Sterility--Reports of loose metal ferrule crimps on vials for injection. The entire cap either lifted or dislodged while attempting to flip off the orange color plastic button.

Pfizer Inc. NDC 0069-0106-01 D-0995-2020
Class II · Moderate risk Terminated

Morphine Sulfate

Reason Lack Of Processing Controls

Redline Pharmacy Solutions D-1011-2020
Class II · Moderate risk Terminated

Daptomycin

Reason Lack Of Processing Controls

Redline Pharmacy Solutions D-1008-2020
Class II · Moderate risk Terminated

Morphine Sulfate

Reason Lack Of Processing Controls

Redline Pharmacy Solutions D-1007-2020
Class II · Moderate risk Terminated

Mesalamine Delayed-Release Tablets

Reason Failed Dissolution Specifications: Low out of specification dissolution result observed during stability testing.

Teva Pharmaceuticals USA NDC 0591-2245-22 D-0862-2020
Class II · Moderate risk Terminated

Desoximetasone Topical Spray

Reason Failed Impurities/Degradation Specification; high out of specification results observed

Lupin Pharmaceuticals Inc. D-0866-2020
Class II · Moderate risk Terminated

Memantine Hydrochloride Extended Release Capsules

Reason Failed Dissolution Specifications: Low out of specification results observed in dissolution test at six-month long-term stability study.

Lupin Pharmaceuticals Inc. NDC 68180-248-06 D-0855-2020
Class II · Moderate risk Terminated

Amoxicillin and Clavulanate Potassium Tablets

Reason Presence of Foreign Substance: Customer complaint of a foreign substance identified as nylon cable tie

AuroMedics Pharma LLC NDC 65862-503-20 D-0852-2020
Class II · Moderate risk Terminated

Desmopressin Acetate Tablets

Reason GMP Deviations: Product bottle may be absent of desiccant.

American Health Packaging D-0849-2020